Literature DB >> 28964381

Outcome of Combined Mitral and Aortic Valve Replacement in Adults With Mucopolysaccharidosis (the Hurler Syndrome).

Clark R Robinson1, William C Roberts2.   

Abstract

We describe 2 adult sisters with type I mucopolysaccharidosis (MPS) who underwent combined mitral and aortic valve replacement for mitral and aortic valve stenosis. One died early postoperatively and the other survived but had a repeat double-valve replacement 1 month after the first. We analyzed previously reported patients with MPS and valve replacement to learn of their outcomes. The study of our 2 patients and those previously reported suggests that valve replacement in patients with MPS should be viewed with extreme caution.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28964381     DOI: 10.1016/j.amjcard.2017.08.001

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  Mitral annular calcification: challenges and future perspectives.

Authors:  Mathias Van Hemelrijck; Maurizio Taramasso; Gökhan Gülmez; Francesco Maisano; Carlos-A Mestres
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-01-27

Review 2.  Surgical Management of Valvular Heart Disease in Mucopolysaccharidoses: A Review of Literature.

Authors:  Barbara A Rosser; Calvin Chan; Andreas Hoschtitzky
Journal:  Biomedicines       Date:  2022-02-04

Review 3.  Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention.

Authors:  Benjamin Cross; Karolina M Stepien; Chaitanya Gadepalli; Ahmed Kharabish; Peter Woolfson; Govind Tol; Petra Jenkins
Journal:  Front Cardiovasc Med       Date:  2022-04-04

4.  Heart valve disease in Hurler-Scheie syndrome.

Authors:  María Del Carmen García Del Rey; Javier Castrodeza; Ángel Pinto; Maria Ángeles Espinosa Castro; Cecilia Muñoz Delgado; Francisco Fernández-Avilés
Journal:  Cardiol J       Date:  2022-07-12       Impact factor: 3.487

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.